According to the International Diabetes Federation (IDF), 366 million people worldwide have diabetes, with numbers expected to increase to 552 million people by 2030. It is also estimated that for every three people with diabetes, one person remains undiagnosed.
“Italian Barometer Diabetes Report 2015”
The main problems to be addressed in this scope are chronic complications and acute episodes that lead to hospitalisation, as well as the risk of developing co-morbidity. The national health service spends 15 billion Euros each year on treating people with diabetes, in addition to the three billion Euros that individuals take out of their own pocket. It has therefore become essential to spread a culture of prevention of complications in both the short and long term, which is closely related to a person’s degree of glycaemic self-control.
The Continuous Glucose Monitoring system (CGM) is therefore of notable importance. This system ensures more effective and efficient adjustment of therapy and the implementation of preventive actions and corrective measures, in order to maintain or restore glycaemia to a normal physiological range and to prevent complications in the short and long term or the insulin pump for more flexibility in patients’ daily life..
Omnipod DASH™ System is a tubeless, waterproof insulin pump designed to manage insulin-dependent diabetes. It consists of two main components only: a tubeless Pod and the phone-like Personal Diabetes Manager (PDM) to be kept at hand to set up wirelessly (Bluetooth®) insulin delivery.
The Continuous Glucose Monitoring (CGM) system is a method to manage diabetes by measuring glucose levels in real time (24 hours a day), thanks to a sensor positioned just under your skin.
Omnipod® System a tubeless, waterproof insulin pump designed to manage insulin-dependent diabetes. It consists of two main components only: a tubeless pod and the handheld Personal Diabetes Manager (PDM) to be kept at hand to set up wirelessly insulin delivery.